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The GP64 and F proteins were previously identified as the sole functional envelope fusion proteins in
Baculoviridae. F-like proteins, present only in group I nucleopolyhedroviruses (NPVs), are remnant, nonfunc-
tional F proteins. In this report, we describe the effect of the presence or absence of the F-like protein Ac23 in
a gp64-null Autographa californica multinucleocapsid NPV pseudotyped with the F protein from Spodoptera
exigua multicapsid NPV (SeF). We found that the presence of Ac23 elevates the infectivity of the pseudotyped
virus. This is in contrast to the results of Lung et al. (J. Virol. 76:5729-5736, 2002), who found no such effect.
The possible reasons for the differing results are discussed.
The entry of enveloped viruses into host cells is usually
mediated by one or more of their envelope proteins. Two types
of envelope fusion proteins, GP64 and F, were identified in
budded viruses (BV) of group I and group II nucleopolyhe-
droviruses (NPVs), respectively (3, 9, 14). These proteins are
responsible for virus binding to cell receptors, for mediating
the fusion of viral and endosomal membranes, and for efficient
budding and egress (1, 2, 5, 6, 11). They are considered to be
the only functional membrane fusion proteins within the Bacu-
loviridae family.
Apart from GP64, group I NPVs also contain F-like pro-
teins, such as those encoded by Ac23 from Autographa califor-
nica multinucleocapsid NPV (AcMNPV) (7) and Op21 from
Orgyia pseudotsugata MNPV (10). These F-like proteins coexist
with GP64 on the surface of BVs (10) and are thought to be
remnants of a functional F. The F-like proteins are structurally
different from F proteins in that the former lack a furin cleav-
age site and thus cannot function as fusion proteins (10). Lung
et al. (7) have shown that Ac23 is not essential for AcMNPV
infection, propagation, and BV production in cell culture but
that it is a viral pathogenicity factor. Insects infected with
AcMNPV lacking Ac23 kill infected insect larvae in a longer
time (7). However, since the F-like proteins are present in
BVs, we hypothesize that the proteins may have function at the
cellular level. Therefore, in the current study, the function of
Ac23 was investigated in the absence of GP64 but in the
presence of a functional but less-fusogenic F protein from
group II NPVs (SeF). We observed that a deletion mutant of
AcMNPV lacking both GP64 and Ac23 but containing SeF
(vAcgp64 Ac23-SeF) produced significantly fewer infectious
BVs than wild-type AcMNPV. This system appeared suitable
to investigate possible auxiliary functions of Ac23 in BV infec-
tion.
To investigate the function of Ac23 in the absence of GP64,
recombinant AcMNPV bacmids were generated (Fig. 1),
namely, the “wild type” control bAc-egfp, with egfp transposed
into the polyhedrin locus; AcMNPV lacking gp64 (bAcgp64)
and AcMNPV lacking both gp64 and Ac23 (bAcgp64 Ac23);
both mutants carrying SeF (bAcgp64-SeF and bAcgp64 Ac23-
SeF), with an egfp and a cat cassette in the gp64 locus; and a
control bacmid, an AcMNPV rescue bacmid with gp64 and
Ac23 reinserted into AcMNPV (bAcgp64 Ac23-gp64-Ac23).
Details of the construction and verification of the bacmids are
in the supplemental material. Recombinant bacmids were
transfected into Sf9 cells, and 4 days posttransfection (p.t.),
green fluorescence was detected in the cells, indicating suc-
cessful transfection (Fig. 2A, panels a, b, c, d, e, and f). At 6
days p.t., a supernatant sample was used to infect another
batch of Sf9 cells, which were inspected 4 days postinfection
(p.i.) for enhanced green fluorescent protein (EGFP) fluores-
cence.
Bacmids bAcgp64 (Fig. 2A, panel b) and bAcgp64 Ac23
(Fig. 2A, panel d) did not produce infectious BVs because of
the absence of the gp64 gene, which is essential for viral entry
and budding, as reported by previous studies (1, 2, 8). How-
ever, with the control bacmid bAc-egfp (Fig. 2A, panel a) and
the full-rescue bacmid bAcgp64 Ac23-gp64-Ac23 (Fig. 2A,
panel f), the transfected cells produced BVs which were able
to infect healthy cells. The F-repaired bacmids bAcgp64-SeF
(Fig. 2A, panel c) and bAcgp64 Ac23-SeF (Fig. 2A, panel e)
were able to produce BVs and generate systemic infections in
the Sf9 cell culture that were comparable to those of control
bacmid-derived BVs (Fig. 2B). These results are consistent
with a previous conclusion that F proteins are functionally
analogous to GP64 (6) and that Ac23 is not essential for BV
production in the presence of GP64 (7). We now demonstrate
that Ac23 is also not essential for BV production when
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AcMNPV is pseudotyped with a functional heterologous F
protein.
To see to what extent Ac23 contributes to the production of
infectious BVs, one-step growth curves of vAc-egfp, vAcgp64-
SeF, vAcgp64 Ac23-SeF, and vAcgp64 Ac23-gp64-Ac23 were
made and compared (Fig. 2B). Sf9 cells were infected with the
respective viruses, and the supernatants sampled at different
time points after infection and tested in an end point dilution
assay (4). The BV production curves were very similar for
vAcgp64 Ac23-gp64-Ac23 and vAc-egfp (F [Fisher’s statis-
tic]  77.604; df [degree of freedom]  1 and 52; P  0.703),
indicating that the reinsertion of gp64 and Ac23 into AcMNPV
not only rescued infectivity but also rescued the BV yields to
wild-type levels. However, in the late phase of infection
vAcgp64 Ac23-SeF produced approximately 100-fold fewer
infectious progeny BV than vAcgp64-SeF (Fig. 2B) and
showed a lower titer of virus (1.04  105 50% tissue culture
infective dose [TCID50] U/ml) than its control virus, vAc
gp64-
SeF (8.31  106 TCID50 U/ml). Thus, vAc
gp64 Ac23-SeF
produced significantly fewer BVs over time than other
pseudotyped viruses (F  77.604; df  3 and 52; P  0.01). In
our study, vAcgp64-SeF exhibited replication kinetics and lev-
els of virus production similar to those of control viruses
vAcgp64 Ac23-gp64-Ac23 and vAc-egfp (F  77.604; df  2
and 52; P  0.066) (Fig. 2B). This is in contrast to what has
been reported previously (6), where SeF-pseudotyped AcM-
NPV never reached wild-type levels. This may be due to dif-
ferences in the promoters driving SeF expression or in the
reporter genes that were used and their locations (see below).
To confirm the correct deletion of gp64 and Ac23 and the
expression and incorporation of the SeF gene in AcMNPV,
Western blot analyses were performed on purified BVs (Fig.
3). GP64 was detected in vAcgp64 Ac23-gp64-Ac23 (lane
A3) and vAc-egfp (lane A4) as 64-kDa bands, but not in
vAcgp64 Ac23-SeF (lane A1) and vAcgp64-SeF (lane A2).
Bands corresponding to Ac23 (approximately 80 kDa) were
detected in vAcgp64-SeF (lane B2), vAcgp64 Ac23-gp64-
Ac23 (lane B3), and vAc-egfp (lane B4), as expected, but not
in vAcgp64 Ac23-SeF (lane B1). The results of these analyses
confirmed the expected AcMNPV gp64-null and Ac23-null
protein phenotypes and demonstrated the successful incorpo-
ration of both gp64 and Ac23 into BVs of the rescued viruses
and the incorporation of Ac23 into the gp64-null AcMNPV
pseudotyped with SeF. A band corresponding to a protein with
a molecular mass identical to the predicted molecular mass of
the cleaved F1 fragment of SeF (60 kDa) (13) was detected in
vAcgp64 Ac23-SeF (lane C1) and vAcgp64-SeF (lane C2),
indicating that the majority of SeF was correctly cleaved by
furin into F1 and F2 subunits and incorporated into the BVs. A
minor band of uncleaved F proprotein SeF0 (80 kDa) was also
present, as shown previously in SeF-pseudotyped Helicoverpa
armigera NPV (12). The antinucleocapsid antibody of VP39
(approximately 39 kDa) (15) was used as an internal control
for the presence of equal amounts of BV extracts in the re-
spective lanes (Fig. 3D).
To investigate whether the reduced infectivity of
vAcgp64 Ac23-SeF was due to lower BV yield or lower infec-
tivity, quantitative real-time PCR was performed on the vari-
ous recombinant viruses, using primers for the amplification of
a 340-bp region of the lef-8 gene (GeneID no. 1403882) (the
methodology is described in the supplemental material). The
quantitative PCR results show that for vAcgp64 Ac23-SeF,
one TCID50 unit tested by end point dilution assay was equiv-
alent to 105 copies of viral genome DNA (Table 1). For the
FIG. 1. Genomic structure of recombinant bacmids bAc-egfp, bAcgp64, bAcgp64-SeF, bAcgp64 Ac23, bAcgp64 Ac23-SeF, bAcgp64 Ac23-gp64-
Ac23 and parental bacmid AcMNPV (bMON14272). Dash-and-dot lines represent the substitution of the corresponding cassettes.
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FIG. 2. Transfection and infection assays of AcMNPV recombinants for viral propagation. (A) Sf9 cells were transfected with bacmids bAc-egfp (a),
bAcgp64 (b), bAcgp64-SeF (c), bAcgp64 Ac23 (d), bAcgp64 Ac23-SeF (e), and bAcgp64 Ac23-gp64-Ac23 (f). One microgram of DNA of each
recombinant bacmid was transfected into 1  106 Sf9 cells in a 35-mm-diameter tissue culture dish by using 12 l Lipofectin reagent according to the
Bac-to-Bac expression system manual (Invitrogen). Six days p.t., supernatants from the transfected cells (panels a, b, c, d, e, and f) were used to infect
healthy Sf9 cells (panels a, b, c, d, e, and f). Levels of infection were recorded by fluorescence at 4 days p.t. or p.i. (B) Results of one-step BV growth
curve analyses of vAc-egfp, vAcgp64-SeF, vAcgp64 Ac23-SeF, and vAcgp64 Ac23-gp64-Ac23. Sf9 cells were infected at a multiplicity of infection of 5
TCID50 U per cell for each virus in triplicate. Titers of progeny viruses at various time points p.i. were determined by performing an end-point dilution
assay (4). Data points represent the mean titers of the triplicate infections, and error bars represent the standard deviations from the means. BV titers
were logarithmically transformed and analyzed by using two-way analysis of variance (SPSS, Inc., 2003) with virus type and time as factors.
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control viruses, vAcgp64 Ac23-SeF, vAcgp64 Ac23-gp64-
Ac23, and vAc-egfp, one TCID50 unit was equivalent to 10
4
copies of viral genome DNA (Table 1). Therefore,
vAcgp64 Ac23-SeF was about 10 times less infectious than the
control viruses (F 33.731; df 3 and 11; P 0.01). However,
according to the end point dilution assay results, the level of
infectious-BV production of vAcgp64 Ac23-SeF was about
100 times lower than the levels for the control viruses, indicat-
ing that the BV yield was also reduced.
Taken together, our results indicate that the presence of
Ac23 contributes to both the yield and the infectivity of BVs in
cell culture. This result is consistent with and provides an
explanation for previous findings that Ac23 is a pathogenicity
factor in vivo and that the infection of insects by AcMNPV is
severely delayed when Ac23 is not present (7). Our findings on
the contribution of Ac23 to the infectivity of BVs also suggest
that the product of Ac23 contributes to the binding process and
may be an accessory protein, which is consistent with indirect
evidence obtained by Zhou and Blissard (16). Although our
construct required the presence of Ac23 to achieve full levels
of infectivity, a construct described by Lung et al. (6) was
defective even when Ac23 was present. The major differences
FIG. 2—Continued.
FIG. 3. Results of Western blot analyses of proteins corresponding to the respective viruses. Lanes for all panels are as follows: 1,
vAcgp64 Ac23-SeF; 2, vAcgp64-SeF; 3, vAcgp64 Ac23-gp64-Ac23; and 4, vAc-egfp. Lane M contains the protein markers, with molecular masses
indicated on the left. BVs were harvested and purified from the supernatants of infected Sf9 cells at 3 days p.i., and the proteins were separated
by 12% sodium dodecyl sulfate-polyacrylamide gel electrophoresis. The blots were probed with antibodies as shown above the panels. The
anti-GP64 antibody used was monoclonal antibody AcV5 at a 1:1,000 dilution.
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between our construct and the one described in reference 6 are
the type and location of the reporter genes used (EGFP-poly-
hedrin locus and GUS-gp64 locus, respectively). In addition,
SeF was expressed from both the gp64 and the polyhedrin
promoter in our construct but only from the gp64 promoter in
the construct of Lung et al. (6). Therefore, the levels of SeF
expressed from our construct may have been higher than in the
construct of Lung et al. (6). However, the precise role that
these different types of reporters and their location and the
promoters used to drive SeF play in the differing properties of
these two constructs remains to be determined.
In summary, the results of our study provide strong support
for the view that the F-like protein Ac23 is a virulence factor
not only in vivo but also in vitro. The F-pseudotyped gp64-null
AcMNPVs used in the current study are considered to be a
useful platform for studying further the function of F-like
proteins in baculovirus infection both in vitro and in vivo.
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TABLE 1. Quantitative PCR for determining viral genome DNA copies compared to viral titers
Recombinant virus Amt of DNA(copies/ml)b
Virus titer
(TCID50 U/ml)a
Viral infectivity
(copies/TCID50 U avg 	 SD
)
vAc-egfp 6.9  1010 6.3  106 (1.1 	 0.1)  104
vAcgp64 Ac23-gp64-Ac23 1.7  1011 1.0  107 (1.7 	 0.7)  104
vAcgp64-SeF 1.9  1011 1.2  107 (1.6 	 0.6)  104
vAcgp64 Ac23-SeF 1.7  1010 1.7  105 (10.0 	 2.0)  104
a Fresh BVs of vAc-egfp, vAcgp64 Ac23-gp64-Ac23, vAcgp64 Ac23-SeF, and vAcgp64-SeF were harvested 96 h p.i. and titrated by end point dilution assay.
b Viral DNAs were extracted, and quantitative PCR was performed to determine genomic DNA copies based on a standard curve.
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